Direct Answer
Bio-Techne reported revenue of $1.2 billion for the fiscal year ended June 30, 2025, with an operating margin of 8.4% and net income of $73 million, according to its SEC filings. Revenue grew 5.2% from the prior year.
What Are Bio-Techne's Key Financial Figures?
| Fiscal year | FY2025 ended June 30, 2025 | FY2024 ended June 30, 2024 | FY2023 ended June 30, 2023 | FY2022 ended June 30, 2022 |
|---|---|---|---|---|
| Revenue | $1.2 billion | $1.2 billion | $1.1 billion | $1.1 billion |
| Operating income | $102 million | $207 million | $299 million | $297 million |
| Operating margin | 8.4% | 17.8% | 26.3% | 26.8% |
| Net income | $73 million | $168 million | $285 million | $272 million |
| Net margin | 6.0% | 14.5% | 25.1% | 24.6% |
| Operating cash flow | $288 million | $299 million | $254 million | $325 million |
| Capital expenditures | $31 million | $63 million | $38 million | $45 million |
| Free cash flow | $257 million | $236 million | $216 million | $280 million |
Operating margin narrowed by 9.4 percentage points between fiscal 2024 and 2025, which separates pricing and cost discipline from revenue growth alone. Free cash flow (operating cash flow minus capital expenditures) was $257 million against net income of $73 million; cash generation covered reported earnings.
What Does Bio-Techne's Balance Sheet Show?
| Cash and cash equivalents | $162 million |
|---|---|
| Long-term debt | $346 million |
| Total assets | $2.6 billion |
| Total liabilities | Not reported |
| Shareholders' equity | $1.9 billion |
| Current ratio | 3.5x |
Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions.
Where These Numbers Come From
Every figure on this page is a value Bio-Techne reported in its own SEC filings, read from the SEC's XBRL data (accession 0001104659-26-100322 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 12, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary.
Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation.
Frequently Asked Questions
What was Bio-Techne's revenue in fiscal 2025?
Bio-Techne reported revenue of $1.2 billion for the fiscal year ended June 30, 2025, according to its SEC filings.
What is Bio-Techne's operating margin?
Bio-Techne's operating margin was 8.4% in fiscal 2025: operating income of $102 million on revenue of $1.2 billion.
How much free cash flow did Bio-Techne generate?
Operating cash flow of $288 million less capital expenditures of $31 million gives free cash flow of $257 million for fiscal 2025.